You are here

  • Home
  • Archive
  • Volume 10, Issue 1
  • Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis

Article info

Article menu
Heart failure and cardiomyopathies
Systematic review
Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis

Authors

  • Hawani Sasmaya Prameswari Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Iwan Cahyo Santosa Putra Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • William Kamarullah Department of Emergency, R Syamsudin SH Regional Public Hospital, Sukabumi, West Java, Indonesia PubMed articlesGoogle scholar articles
  • Raymond Pranata Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Mohammad Iqbal Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Giky Karwiky Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Miftah Pramudyo Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Nuraini Yasmin Kusumawardhani Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, IndonesiaDepartment of Internal Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Chaerul Achmad Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Januar Wibawa Martha Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  • Mohammad Rizki Akbar Department of Cardiology and Vascular Medicine, University of Padjadjaran Faculty of Medicine, Bandung, Jawa Barat, Indonesia PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Hawani Sasmaya Prameswari; hawanisasmaya{at}gmail.com
View Full Text

Citation

Prameswari HS, Putra ICS, Kamarullah W, et al
Role of N-terminal pro-B type natriuretic peptide as a predictor of poor outcomes in patients with HFrEF receiving primary prevention implantable cardioverter-defibrillator therapy: a systematic review and dose–response meta-analysis
Open Heart 2023;10:e002225. doi: 10.1136/openhrt-2022-002225

Publication history

  • Received December 2, 2022
  • Accepted February 27, 2023
  • First published March 16, 2023.
Online issue publication 
March 16, 2023

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.